PHAR vs IOVA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 31, 2026

PHAR

44.0
AI Score
VS
PHAR Wins

IOVA

36.1
AI Score

Investment Advisor Scores

PHAR

44score
Recommendation
HOLD

IOVA

36score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric PHAR IOVA Winner
Forward P/E 270.2703 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -3.2% 65.7% IOVA
Earnings Growth -62.9% 0.0% IOVA
Tradestie Score 44.0/100 36.1/100 PHAR
Profit Margin 2.5% -89.1% PHAR
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

PHAR 1M: +13.9% · 3M: -12.4% IOVA 1M: +100.7% · 3M: +106.3%

Current Technical Phase

PHAR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.8%), weak momentum, RSI 45

RSI (14): 44.6 · Price: $11.48

IOVA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (28.9% over 20 days), RSI 65

RSI (14): 65.0 · Price: $8.17

Fundamentals Snapshot

Metric PHAR IOVA
Market Cap
Forward P/E 37.4 -28.4
Trailing P/E 83.6
Revenue (TTM)
Revenue Growth 0.0% 0.7%
Gross Margin 0.9% 0.5%
Operating Margin 0.0% -0.5%
EPS 0.14 -0.69
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PHAR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.